01/30/2015 - 1:13pm
Prezcobix from Janssen Therapeutics granted FDA approval

Janssen Therapeutics on Thursday announced that the Food and Drug Administration has approved its Prezcobix (darunavir 800 mg/cobicistat 150 mg) tablets. The drug is used to treat human immunodeficiency virus in combination with other antiretovirals for treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions, according to the company.

 

01/30/2015 - 10:25am
BioPlus Specialty Pharmacy earns URAC accreditation

BioPlus Specialty Pharmacy announced Thursday that URAC, the largest accrediting body for health care, has once again given BioPlus its seal of approval by accrediting it through an on-site process.

01/30/2015 - 10:21am
FDA expands indication for Imbruvica

Diplomat Pharmacy announced Thursday that the Food and Drug Administration has approved an expanded indication of Imbruvica (ibrutinib) for the treatment of Waldenström’s macroglobulinemia (WM).

01/29/2015 - 3:09pm
Rx trends 2015: Managing the newly insured

If its goal of expanding health coverage to more Americans is fully realized, the Affordable Care Act could end up pulling as many as 30 million more people into the ranks of the newly insured. That means rising prescription counts and more patients at pharmacy counters and in drug store aisles, but it also poses challenges in managing and educating patients about their benefits.

 

01/29/2015 - 1:47pm
Cardinal, CVS Health generics sourcing venture tracking ahead of plan

Cardinal Health increased full-year share earnings projections to a range of $4.28 to $4.38, in part driven by a faster-than-expected start for its generics sourcing venture with CVS Health.

01/29/2015 - 10:01am
San Diego researchers improve accuracy of Google Flu Trends

Three UC San Diego researchers say they can predict the spread of flu a week into the future with as much accuracy as Google Flu Trends can display levels of infection right now.

 

01/28/2015 - 4:34pm
Provider status bill: Look how far you have come!

"During one of the sessions at the 2008 NACDS Regional Chain Conference, we projected onto the video screen some images of advertisements that NACDS was beginning to use in the Washington, D.C. area. Looking back, one of the things that I remember most was the boldness and strategic focus of the tagline: 'Pharmacies. The face of neighborhood healthcare.' With the 2015 edition of this meeting just days away, it is striking how far we have come!" writes NACDS president and CEO Steve Anderson in his latest blog post. 

01/28/2015 - 3:11pm
Rx trends 2015: Telehealth

Doctors making house calls? It sounds so …19th century, conjuring up images of a tweedy medical practitioner arriving on someone’s doorstep by horse and buggy with a medical bag and a stethoscope. 

01/28/2015 - 1:53pm
House Energy and Commerce Committee releases white paper on 21st Century Cures initiative

The House Energy and Commerce Committee on Tuesday released a discussion document in the 21st Century Cures initiative.

01/28/2015 - 12:44pm
Cardinal Health Specialty Solutions signs agreement with RainTree Oncology Services

Cardinal Health Specialty Solutions on Tuesday announced that it has signed a three-year agreement with RainTree Oncology Services to serve as its exclusive distributor for injectable, infused, oral oncolytic and supportive care specialty medications.